From revenues of $67 billion in 2012 for Johnson & Johnson, to $6 billion for Actavis Inc., pharma companies had a relatively strong showing last year, according to the IW US 500.
Check out IW's complete catalog of IW U.S. 500 and IW 1000 slideshows.
